Price$1.84+0.00 (+0.00%)
02:30 PM07:45 PM
News · 26 weeks66+260%
2025-12-282026-06-21
Mix2790d
- Insider14(52%)
- SEC Filings9(33%)
- Earnings1(4%)
- Leadership1(4%)
- Analyst1(4%)
- Other1(4%)
Latest news
25 items- PRSERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY--Aligns With Growing Focus on Early Identification and Management of Preterm Birth Risk--SALT LAKE CITY, June 23, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ:SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information, today acknowledged recent legislative action in Illinois aimed at expanding access to evidence-based approaches for identifying and managing the risk of preterm birth among pregnant individuals. The legislation amends the Illinois Public Aid Code to require the state's medical assistance program (Medicaid) to provide coverage and
- INSIDERChief Financial Officer Aerts Austin sold $4,094 worth of shares (2,037 units at $2.01), decreasing direct ownership by 0.67% to 301,190 units (SEC Form 4) (tax withholding)4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)
- INSIDERChief Commercial Officer Anderson Dyaarl Lee Jr. sold $9,525 worth of shares (4,739 units at $2.01), decreasing direct ownership by 6% to 77,998 units (SEC Form 4) (tax withholding)4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)
- INSIDERGeneral Counsel Jackson Benjamin sold $4,380 worth of shares (2,179 units at $2.01), decreasing direct ownership by 1% to 161,756 units (SEC Form 4) to satisfy tax liability4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)
- INSIDERChief Medical Officer Inglis Tiffany Eul Davis sold $728 worth of shares (362 units at $2.01), decreasing direct ownership by 0.39% to 92,075 units (SEC Form 4) (tax liability)4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)
- INSIDERChief Executive Officer Lindgardt Zhenya sold $14,050 worth of shares (6,990 units at $2.01), decreasing direct ownership by 0.80% to 865,009 units (SEC Form 4) (tax withholding)4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)
- INSIDERChief Executive Officer Lindgardt Zhenya sold $43,170 worth of shares (20,755 units at $2.08), decreasing direct ownership by 2% to 871,999 units (SEC Form 4) (withholding obligation)4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)
- INSIDERChief Financial Officer Aerts Austin sold $11,315 worth of shares (5,440 units at $2.08), decreasing direct ownership by 2% to 303,227 units (SEC Form 4) (tax liability)4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)
- INSIDERDirector Lawrence Sandra Aj sold $3,354 worth of shares (1,560 units at $2.15) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 16,473 units (SEC Form 4)4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)
- SECSEC Form 144 filed by Sera Prognostics Inc.144 - SERA PROGNOSTICS, INC. (0001534969) (Subject)
- SECSera Prognostics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - SERA PROGNOSTICS, INC. (0001534969) (Filer)
- INSIDERSEC Form 4 filed by Director Elliott Jeffrey Thomas4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)
- ANALYSTCraig Hallum initiated coverage on Sera Prognostics with a new price targetCraig Hallum initiated coverage of Sera Prognostics with a rating of Buy and set a new price target of $6.00
- INSIDERGeneral Counsel Jackson Benjamin was granted 5,000 shares, increasing direct ownership by 3% to 163,935 units (SEC Form 4)4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)
- INSIDERChief Commercial Officer Anderson Dyaarl Lee Jr. was granted 3,168 shares, increasing direct ownership by 4% to 82,737 units (SEC Form 4)4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)
- SECSEC Form DEFA14A filed by Sera Prognostics Inc.DEFA14A - SERA PROGNOSTICS, INC. (0001534969) (Filer)
- SECSera Prognostics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - SERA PROGNOSTICS, INC. (0001534969) (Filer)
- PRSERA PROGNOSTICS ANNOUNCES BOARD TRANSITIONSALT LAKE CITY, June 1, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ:SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that Jeff Elliott has notified the Company of his intention to step down from its Board of Directors, effective June 4, 2026, and that he will not stand for re-election at the Company's upcoming Annual Meeting of Shareholders. Mr. Elliott has served on Sera's Board since March 2025, providing strategic guidance and leadership during a period of growth and development for the Comp
- INSIDERSEC Form 4 filed by Chief Data Officer Kearney Paul4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)
- INSIDERSEC Form 4 filed by Chief Information Officer Harrison Robert Gardner4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)
- INSIDERSEC Form 4 filed by Chief Scientific Officer Boniface John J.4 - SERA PROGNOSTICS, INC. (0001534969) (Issuer)
- SECSEC Form 10-Q filed by Sera Prognostics Inc.10-Q - SERA PROGNOSTICS, INC. (0001534969) (Filer)
- SECSera Prognostics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SERA PROGNOSTICS, INC. (0001534969) (Filer)
- SECSEC Form DEFA14A filed by Sera Prognostics Inc.DEFA14A - SERA PROGNOSTICS, INC. (0001534969) (Filer)
- SECSEC Form DEF 14A filed by Sera Prognostics Inc.DEF 14A - SERA PROGNOSTICS, INC. (0001534969) (Filer)
SERA FAQ
7 questionsWhat does Sera Prognostics Inc. do?
Sera Prognostics, Inc., a health diagnostic company, discovers, develops, and commercializes biomarker tests for the early prediction of preterm birth risk and other complications of pregnancy. It develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.Where does SERA stock trade?
Sera Prognostics Inc. (SERA) is listed on NASDAQ.What sector and industry is SERA in?
Sera Prognostics Inc. operates in the Health Care sector, Medical Specialities industry.When did Sera Prognostics Inc. go public?
Sera Prognostics Inc. (SERA) completed its IPO in 2021.What are analysts saying about SERA?
Sera Prognostics Inc. has had 8 recent analyst actions on file. The most recent action was from Craig Hallum: Buy with a $600.00 price target on 2026-06-04. Recent price targets range from $400.00 to $1900.00.What companies are similar to SERA?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.). Compare SERA side-by-side with any of them on Quantisnow.How can I track SERA on Quantisnow?
Quantisnow aggregates Sera Prognostics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SERA to receive live email and push alerts on every new disclosure.